Leerink Partners Reiterates Outperform Rating on Evommune Inc (EVMN): "we remain encouraged by EVMN’s execution"
Tweet Send to a Friend
Leerink Partners analyst Thomas Smith reiterated an Outperform rating and $52.00 price target on Evommune Inc (NYSE: EVMN)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
